Literature DB >> 17761358

Association of patient-reported psoriasis severity with income and employment.

Elizabeth J Horn1, Kathleen M Fox, Vaishali Patel, Chiun-Fang Chiou, Frank Dann, Mark Lebwohl.   

Abstract

OBJECTIVE: We sought to examine whether psoriasis severity was associated with patient income and employment.
METHODS: Respondents (> 30 years old) to National Psoriasis Foundation surveys (2003-2005) were classified by reported body surface area as having mild (< 3%), moderate (3%-10%), or severe (> 10%) psoriasis. The relationship between severity and household income (< $30,000 vs > or = $30,000) and employment was assessed by logistic regression, adjusting for age, age at onset, sex, race, and drug treatment.
RESULTS: Probability of low income (< $30,000) was significantly greater among patients with severe disease than those with mild disease (P = .0002). Patients with severe disease had lower probability of working full time compared with patients with mild psoriasis but it was not statistically significant. Significantly more patients with severe psoriasis (17%) versus mild (6%) reported that psoriasis was the reason for not working (P = .01). LIMITATIONS: Household income was self-reported and may be influenced by household composition, which is unknown. Psoriasis severity was patient reported and not physician assessed.
CONCLUSIONS: This study demonstrated that income and employment were negatively impacted among patients with severe psoriasis compared with mild psoriasis.

Entities:  

Mesh:

Year:  2007        PMID: 17761358     DOI: 10.1016/j.jaad.2007.07.023

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  20 in total

Review 1.  Update on the natural history and systemic treatment of psoriasis.

Authors:  Stephen K Richardson; Joel M Gelfand
Journal:  Adv Dermatol       Date:  2008

Review 2.  The latest advances in pharmacogenetics and pharmacogenomics in the treatment of psoriasis.

Authors:  Caitriona Ryan; Alan Menter; Richard B Warren
Journal:  Mol Diagn Ther       Date:  2010-04-01       Impact factor: 4.074

Review 3.  The burden of moderate to severe psoriasis: an overview.

Authors:  Giovanna Raho; Daniela Mihajlova Koleva; Livio Garattini; Luigi Naldi
Journal:  Pharmacoeconomics       Date:  2012-11-01       Impact factor: 4.981

Review 4.  The Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives.

Authors:  Steven R Feldman; Bernard Goffe; Gary Rice; Matthew Mitchell; Mandeep Kaur; Debbie Robertson; Debra Sierka; Jeffrey A Bourret; Tamara S Evans; Alice Gottlieb
Journal:  Am Health Drug Benefits       Date:  2016-12

Review 5.  Use of Kv1.3 blockers for inflammatory skin conditions.

Authors:  W Nguyen; B L Howard; D S Neale; P E Thompson; P J White; H Wulff; D T Manallack
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

Review 6.  Current and potential immune therapies and vaccines in the management of psoriasis.

Authors:  Benjamin H Kaffenberger; Grace L Lee; Kelly Tyler; Derek V Chan; Wael Jarjour; Maria E Ariza; Marshall V Williams; Henry K Wong
Journal:  Hum Vaccin Immunother       Date:  2014-02-03       Impact factor: 3.452

7.  Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan.

Authors:  Abdul Rahman Khawaja; Syed Muhammad Azam Bokhari; Rasheed Tariq; Shahzad Atif; Hanif Muhammad; Qadeer Faisal; Mohammad Jafferany
Journal:  Prim Care Companion CNS Disord       Date:  2015-06-25

8.  Analysis of the relationship between psoriasis symptom severity and quality of life, work productivity, and activity impairment among patients with moderate-to-severe psoriasis using structural equation modeling.

Authors:  Colin Lewis-Beck; Safiya Abouzaid; Lin Xie; Onur Baser; Edward Kim
Journal:  Patient Prefer Adherence       Date:  2013-03-11       Impact factor: 2.711

9.  Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003-2011.

Authors:  April W Armstrong; Clayton Schupp; Julie Wu; Bruce Bebo
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

10.  Moderate and severe plaque psoriasis: cost-of-illness study in Italy.

Authors:  Gl Colombo; Gf Altomare; K Peris; P Martini; G Quarta; M Congedo; A Costanzo; A Di Cesare; E Lapucci; S Chimenti
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.